Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics
Subcutaneous immunotherapy is the only treatment that improves the natural progression of allergic rhinitis and maintains long-term outcomes after discontinuation of the drug. Metabolomics is increasingly applied in the study of allergic diseases, including allergic rhinitis. However, little is know...
Saved in:
Main Authors: | Hai-Yun Shi (Author), Chen Pan (Author), Ting-Ting Ma (Author), Yan-Lei Chen (Author), Wei-Jun Yan (Author), Jian-Guo Liu (Author), Meng-Da Cao (Author), Hong-Dong Huang (Author), De-Yun Wang (Author), Xue-Yan Wang (Author), Ji-Fu Wei (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial
by: Qiao-yan Chen, et al.
Published: (2018) -
Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis
by: Yin Li, et al.
Published: (2024) -
Allergic rhinitis caused by plant pollen in adolescents
by: G. M. Nurtdinova, et al.
Published: (2023) -
Update about Oralair® as a treatment for grass pollen allergic rhinitis
by: L. Klimek, et al.
Published: (2022) -
Skin prick tests and subcutaneous immunotherapy with standardized allergens in children with moderate-to-severe allergic rhinitis
by: Nihar Ranjan Mishra, et al.
Published: (2021)